Rabbit Anti thymocyte globulin

DRUG2 trials

Sponsors

Vastra Gotaland Region, Washington University School of Medicine

Conditions

AML, ChildhoodAcute Myeloid LeukemiaAcute Myeloid Leukemia, PediatricAllograftsAmlLung Transplantation

Phase 1

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

RecruitingNCT06158828

Washington University School of MedicineAcute Myeloid Leukemia, Acute Myeloid Leukemia, Pediatric, Aml +1

Start: 2024-11-15End: 2030-05-31Target: 68Updated: 2026-08-24

Unknown Phase

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

Active, not recruitingNCT02936505

Vastra Gotaland RegionAllografts, Lung Transplantation

Start: 2016-10-12End: 2026-10-30Updated: 2023-04-26

Related Papers

NK Cell Immunotherapy to Reduce Relapse after Haploidentical Transplant for High-Risk Pediatric and Young Adult AML

Blood2024-11-05

Design and Rationale of Cytokine Filtration in Lung Transplantation (GLUSorb): Protocol for a Multicenter Clinical Randomized Controlled Trial

JMIR Research Protocols2023-10-024 citations

Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial.

2023-09-1023 citations

Design and Rationale of a Scandinavian Multicenter Randomized Study Evaluating if Once-Daily Tacrolimus Versus Twice-Daily Cyclosporine Reduces the 3-year Incidence of Chronic Lung Allograft Dysfunction After Lung Transplantation (ScanCLAD Study)

Advances in Therapy2020-01-289 citations